Screener
Wave Life Sciences WVE Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -68.3%— | -53.7%— | -56.2%— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 10×+7.4× | 11.3×+8.3× | 6.5×+3.6× | 2.5×+0.6× | 2.6×+1.6× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×-0.1× | 0×-0.1× | 0×-0.1× | 0.2×0.0× | 0.2×— | |
| Per Share | ||||||
| Book value per share | $2.22+162% | $2.56+142% | $3.07+103% | $0.74-30.5% | $0.85+3,269% | |
| Valuation | ||||||
| Market capitalization | $1.2B-6.8% | $1.36B+10.1% | $3.16B+67.4% | $1.17B+9.7% | $1.06B+64.7% | |
| Price / book | 2.7×-6.6× | 2.7×-4.6× | 6.1×-2.9× | 9.4×+1.9× | 7.6×— |
FAQ
- Where do Wave Life Sciences's ratios come from?
- Every ratio is computed from Wave Life Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
